ŌURA Tops Up Its Funds for Next Year

It has been a busy year for Finnish smart ring maker ŌURA with new partnerships and acquisitions. The company is now ending the year by raising $200 million in a Series D funding round, bringing its valuation to $5.2 billion.

“We’ve made significant progress in advancing our mission to make health a daily practice and will use this funding to unlock new opportunities, with AI development at the center of our strategy,” said CEO Tom Hale at the San Francisco office.

The funding, led by Fidelity Management & Research Co. and glucose biosensing leader Dexcom, will enable ŌURA to expand its product offerings, invest further in AI and healthcare innovation, and pursue global expansion efforts. Acquisitions are also planned to accelerate growth.

This year, ŌURA forged a strategic partnership with Dexcom, acquired Sparta Science and Veri, and launched the Oura Ring 4, which features advanced Smart Sensing technology. The company also introduced Oura Labs, a platform for testing features like Symptom Radar.

Founded in 2013 in Finland, ŌURA has established itself as a leader in wearable tech. Its Oura Ring tracks sleep, activity, stress, and other health metrics. The company operates from Oulu, Helsinki, San Francisco, and San Diego offices.

Also read: